| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 36 |
| 1 | VEDOLIZUMAB | 25 |
| 2 | USTEKINUMAB | 19 |
| 3 | PREDNISOLONE | 18 |
| 4 | PREDNISOLONE ORAL | 18 |
| 5 | PREDNISOLONE ORAL SOLUTION | 18 |
| 6 | AZATHIOPRINE | 17 |
| 7 | ADALIMUMAB-AATY | 16 |
| 8 | PREDNISONE | 13 |
| 9 | ADALIMUMAB-ADAZ | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETRASIMOD | 8 | 0.0047 |
| 1 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 2 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 3 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 4 | HYALURONATE SODIUM | 1 | 0.0007 |
| 5 | SENNOSIDES A AND B | 1 | 0.0006 |
| 6 | UREA | 1 | 0.0005 |
| 7 | OLMESARTAN MEDOXOMIL-HYDROCHLOROTHIAZIDE | 3 | 0.0004 |
| 8 | ADALIMUMAB-AATY | 16 | 0.0003 |
| 9 | VEDOLIZUMAB | 25 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 31 |
| 1 | Integrin Receptor Antagonist [EPC] | 25 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 3 | Interleukin-12 Antagonist [EPC] | 19 |
| 4 | Interleukin-23 Antagonist [EPC] | 19 |
| 5 | Purine Antimetabolite [EPC] | 17 |
| 6 | Aminosalicylate [EPC] | 11 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 10 |
| 8 | Janus Kinase Inhibitor [EPC] | 9 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 25 | 0.0003 |
| 1 | Interleukin-12 Antagonist [EPC] | 19 | 0.0002 |
| 2 | Interleukin-23 Antagonist [EPC] | 19 | 0.0002 |
| 3 | Purine Antimetabolite [EPC] | 17 | 0.0002 |
| 4 | Nitroimidazole Antimicrobial [EPC] | 10 | 0.0002 |
| 5 | Aminosalicylate [EPC] | 11 | 0.0001 |
| 6 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 9 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |